Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin G Bitler

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Cell Reports|November 4, 2015
SPOP E3 Ubiquitin Ligase Adaptor Promotes Cellular Senescence by Degrading the SENP7 deSUMOylaseHengrui Zhu, Shancheng Ren, Benjamin G Bitler, et al.
Journal of Mammary Gland Biology and Neoplasia|April 30, 2017
Developmental Expression of Claudins in the Mammary GlandHeidi K Baumgartner, Michael C Rudolph, Palaniappian Ramanathan, et al.
Traffic (Copenhagen, Denmark)|July 5, 2011
Derlin-dependent retrograde transport from endosomes to the Golgi apparatusHope Dang, Tove I Klokk, Basil Schaheen, et al.
Molecular Cancer Research : MCR|March 22, 2020
Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer ProgressionBrandon T Sawyer, Lubna Qamar, Tomomi M Yamamoto, et al.
Plos Computational Biology|September 21, 2023
A platform-independent framework for phenotyping of multiplex tissue imaging dataMansooreh Ahmadian, Christian Rickert, Angela Minic, et al.
Cancer Immunology Research|December 1, 2021
The SETDB1-TRIM28 Complex Suppresses Antitumor ImmunityJianhuang Lin, Dajiang Guo, Heng Liu, et al.
Clinical Epigenetics|November 29, 2019
Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinomaZachary L Watson, Tomomi M Yamamoto, Alexandra McMellen, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in <i>CTNNB1</i>-mutated endometrial cancerBradley R Corr, Marisa R Moroney, Elizabeth Woodruff, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 7, 2011
ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approachesHua Li, Benjamin G Bitler, Vinod Vathipadiekal, et al.
Molecular Cancer Therapeutics|January 24, 2026
Chromobox2 inhibition: a novel activity of alisertib, an aurora A kinase inhibitorTomomi M Yamamoto, Ritsuko Iwanaga, Elizabeth R Woodruff, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Cell Reports|November 4, 2015
SPOP E3 Ubiquitin Ligase Adaptor Promotes Cellular Senescence by Degrading the SENP7 deSUMOylaseHengrui Zhu, Shancheng Ren, Benjamin G Bitler, et al.
Journal of Mammary Gland Biology and Neoplasia|April 30, 2017
Developmental Expression of Claudins in the Mammary GlandHeidi K Baumgartner, Michael C Rudolph, Palaniappian Ramanathan, et al.
Traffic (Copenhagen, Denmark)|July 5, 2011
Derlin-dependent retrograde transport from endosomes to the Golgi apparatusHope Dang, Tove I Klokk, Basil Schaheen, et al.
Molecular Cancer Research : MCR|March 22, 2020
Targeting Fatty Acid Oxidation to Promote Anoikis and Inhibit Ovarian Cancer ProgressionBrandon T Sawyer, Lubna Qamar, Tomomi M Yamamoto, et al.
Plos Computational Biology|September 21, 2023
A platform-independent framework for phenotyping of multiplex tissue imaging dataMansooreh Ahmadian, Christian Rickert, Angela Minic, et al.
Cancer Immunology Research|December 1, 2021
The SETDB1-TRIM28 Complex Suppresses Antitumor ImmunityJianhuang Lin, Dajiang Guo, Heng Liu, et al.
Clinical Epigenetics|November 29, 2019
Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinomaZachary L Watson, Tomomi M Yamamoto, Alexandra McMellen, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in <i>CTNNB1</i>-mutated endometrial cancerBradley R Corr, Marisa R Moroney, Elizabeth Woodruff, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 7, 2011
ALDH1A1 is a novel EZH2 target gene in epithelial ovarian cancer identified by genome-wide approachesHua Li, Benjamin G Bitler, Vinod Vathipadiekal, et al.
Molecular Cancer Therapeutics|January 24, 2026
Chromobox2 inhibition: a novel activity of alisertib, an aurora A kinase inhibitorTomomi M Yamamoto, Ritsuko Iwanaga, Elizabeth R Woodruff, et al.
Pageof 12